Skip to content
Lawsuit Help Desk

Lawsuit News Center

Unlocking the Future of Oncology: How Precision Therapies and Artificial Intelligence are Revolutionizing Cancer Treatment

Unlocking the Future of Oncology: How Precision Therapies and Artificial Intelligence are Revolutionizing Cancer Treatment

The transformation in cancer treatment is driven by precision oncology therapies and artificial intelligence (AI), doubling patient applicability in five years. Precision oncology, which constitutes half of the oncology drugs approved post-1998, leverages genetic profiles to create personalized treatments, reducing harm to healthy cells. Upgrades include liquid biopsies, non-invasive blood tests, and biomarker-guided therapies. However, cancer mortality rates are higher among racial minorities due to disparities in clinical trials and lack of access to relevant information. Further evolution in treatment involves AI and machine learning for early detection and better prognosis. Novel therapies like the CDK7 inhibitor and pembrolizumab show promise for more efficient treatment. To maximize these advancements, it is crucial to address clinical trial participation disparities to expand benefits to all ethnic groups and races. The future of oncology, where every life matters, and no one is left behind, is already here.

Full article here: https://ipllfirm.com/all-insights/news-and-articles/unlocking-the-future-of-oncology-how-precision-therapies-and-artificial-intelligence-are-revolutionizing-cancer-treatment/